Browse the evidence

Myostatin inhibitors (e.g., neutralizing antibodies, soluble receptor decoys) increase muscle mass and strength but are associated with significant side effects, limiting their current utility.

Myostatin inhibitors are investigational drugs that can increase muscle mass and strength but are currently limited by significant side effects like fatigue, confusion, and muscle contractions. They are not yet standard treatments.

Gut microbiota composition influences the efficacy of metabolic treatments like bariatric surgery and metformin, and contributes to vagal desensitization in obesity.

If you are on metformin or had bariatric surgery, your gut bacteria matter. A diet that supports a healthy microbiome can enhance the effectiveness of these treatments. Conversely, a poor diet may contribute to 'vagal desensitization,' making weight loss harder.

Dietary intake of medium-chain fatty acids (MCFAs) from sources like virgin coconut oil can increase the Bacteroidetes/Firmicutes ratio and reduce obesity and inflammatory bowel disease (IBD) in animal models, although high-concentration coconut oil diets may have the opposite effect.

Focus on the quality of fats rather than just avoiding fat. Moderate intake of medium-chain fatty acids (found in coconut oil) may support a healthy gut microbiome and reduce inflammation in animal studies, but very high intake of coconut oil might have negative effects. Balance is key.

High intake of long-chain fatty acids (LCFAs), particularly from saturated sources like palm oil and lard, increases the Firmicutes to Bacteroidetes ratio, leading to obesity, insulin resistance, and inflammatory bowel disease in animal models.

Limit high intake of saturated long-chain fatty acids (found in palm oil, lard, and large amounts of butter). These are linked to negative gut microbiota changes and metabolic issues in animal studies. Opt for unsaturated fats like olive oil (MUFAs) or fish oil (PUFAs) for better metabolic health.

Consumption of Daucus carota (carrots) provides bioactive phytochemicals (phenolics, carotenoids, polyacetylenes, and ascorbic acid) that reduce the risk of cardiovascular disease and cancer through antioxidant, anti-inflammatory, and lipid-modifying mechanisms.

Eat carrots regularly. Different colors offer different benefits: orange for eye/immune health (beta-carotene), purple/black for heart health and cancer risk reduction (anthocyanins/phenolics), and yellow for eye health (lutein). You don't need to buy expensive specialty varieties; standard orange carrots provide significant provitamin A. Processing (like blanching) can increase some phenolics, but cooking methods vary in their effect on other nutrients.

Combined oral administration of Scutellariae Radix and Coptidis Rhizoma extracts improves glucose and lipid metabolism in Type 2 Diabetes Mellitus (T2DM) models by downregulating the MAPK inflammatory pathway and upregulating the PI3K/Akt insulin signaling pathway.

This research suggests that a specific combination of Scutellariae Radix and Coptidis Rhizoma extracts may help regulate blood sugar and lipids in T2DM by reducing inflammation and improving insulin signaling. However, this is an animal study; human dosing, safety, and efficacy are not established here. Do not self-medicate with these herbs based on this paper alone.

Higher gut microbial alpha diversity is associated with lower arterial stiffness (measured by carotid-femoral pulse wave velocity) in middle-aged women, independent of traditional cardiovascular risk factors.

For women, maintaining a diverse gut microbiome through a fiber-rich diet may support arterial health. While this study does not prove that changing your diet will directly lower blood pressure or stiffness, it highlights that the microbes in your gut are linked to how stiff your arteries are, a key marker of cardiovascular aging. Focus on dietary diversity to support microbial richness.

Administration of ursodeoxycholic acid (UDCA) attenuates high-fat diet-induced obesity in mice by increasing hepatic levels of non-12-hydroxylated bile acids (non-12-OH BAs), which enhances GLP-1 secretion and upregulates UCP1 and PGC1a in brown adipose tissue.

This research suggests that ursodeoxycholic acid (UDCA) may help prevent obesity in the context of a high-fat diet by boosting beneficial bile acids (non-12-OH BAs). These bile acids signal the body to burn more energy (via UCP1 in fat tissue) and release satiety hormones (GLP-1). While this is a promising therapeutic avenue, it is currently based on animal models. For humans, maintaining a healthy weight through diet and exercise remains the primary strategy, but this mechanism highlights why bile acid health is important for metabolic function.

Exercise provides an anti-ageing effect by preventing telomere shortening and modifying DNA methylation patterns, which may mitigate age-related bone loss and osteoporosis.

Engage in regular exercise, especially after age 40, not just for muscle or weight, but for cellular health. This helps protect your telomeres and DNA methylation patterns, which are linked to how fast your body ages and your risk of bone diseases.

Sugar-sweetened beverage taxes are economically justified if they correct for externalities (healthcare costs) and internalities (self-control issues/misinformation), potentially exceeding their costs even if regressive in direct financial impact.

For policymakers: Implement SSB taxes to correct for health externalities and internalities, not just to raise revenue. Target taxes on grams of sugar, not just volume, and consider revenue recycling to benefit low-income communities. The net social benefit likely exceeds the costs.

Higher serum levels of indolepropionic acid (IPA), a gut microbiota metabolite derived from dietary tryptophan, are associated with a lower incidence of type 2 diabetes and reduced low-grade inflammation in high-risk individuals.

While you cannot directly supplement IPA effectively based on this study, the findings suggest that a diet high in fiber supports gut bacteria that produce IPA. This metabolic pathway is linked to lower inflammation and a reduced risk of type 2 diabetes. Prioritize fiber-rich whole foods to support this natural protective mechanism.

Inhibiting adipogenesis (the differentiation of preadipocytes into mature adipocytes) via modulation of transcription factors (C/EBP, PPARγ) and signaling pathways (Wnt, AMPK) is a viable therapeutic strategy for preventing or treating obesity.

This paper does not provide a direct lifestyle protocol but identifies the biological target: stopping the creation of new fat cells. For a layperson, this implies that interventions aiming to reduce obesity should focus on mechanisms that inhibit fat cell differentiation, such as those found in certain natural products or drugs targeting PPARγ or AMPK pathways, rather than just calorie restriction alone.

Natural products and conventional medications (Statins, Fibrates, Niacin) can inhibit or modulate adipogenesis through specific molecular pathways, offering potential anti-obesity effects.

Current medications like Statins and Fibrates, and various natural products, affect fat cell biology. Statins decrease lipid accumulation and increase small adipocytes. Fibrates increase fatty acid oxidation. Niacin stimulates adipogenesis markers. These mechanisms suggest that existing drugs have off-target effects on fat biology that could be leveraged.

Elevated circulating branched-chain amino acid (BCAA) levels are strongly associated with insulin resistance and type 2 diabetes, potentially acting as mediators through mTORC1 activation and accumulation of toxic metabolites like acylcarnitines and ceramides.

If you have insulin resistance or type 2 diabetes, high levels of branched-chain amino acids (found in protein) in your blood are linked to worse metabolic health. While protein is essential, simply consuming more BCAAs may not help and could potentially worsen insulin resistance in susceptible individuals. Focus on overall metabolic health and consult a provider before high-dose BCAA supplementation.

Bariatric surgery, specifically Roux-en-Y gastric bypass, reduces BCAA levels and improves insulin sensitivity, an effect not seen with weight loss alone via gastric banding.

If you undergo Roux-en-Y gastric bypass, your BCAA levels are likely to drop, which helps improve insulin sensitivity. This benefit is specific to the type of surgery and not just weight loss.

More green space in a neighborhood tends to be associated with a lower risk and prevalence of type 2 diabetes mellitus (T2DM), although the evidence is not as strong as for walkability.

While the evidence is not conclusive, living in an area with more green space may be associated with a lower risk of type 2 diabetes. This could be due to increased physical activity or stress reduction.

Inhibition of the host enzyme indoleamine 2,3-dioxygenase 1 (IDO1) improves metabolic health by shifting tryptophan metabolism toward gut microbiota-derived indole metabolites, which restore intestinal barrier integrity and reduce systemic inflammation.

To support metabolic health, prioritize dietary patterns that foster a diverse gut microbiome capable of converting dietary tryptophan into protective indole metabolites. This involves consuming sufficient fiber and diverse plant sources. Emerging research suggests that inhibiting the host enzyme IDO1 (which is upregulated in obesity) allows the microbiota to produce more of these beneficial indoles, thereby improving insulin sensitivity and reducing inflammation. While direct IDO1 inhibitors are not yet standard care, supporting the microbiome's ability to perform this conversion is a key mechanistic target.

Dietary tryptophan metabolism via the kynurenine pathway (specifically IDO1 activity) is shifted toward protective indole metabolites when gut barrier integrity is maintained, whereas high-fat diets and inflammation shift it toward kynurenine, promoting inflammation and metabolic disease.

Your body processes dietary tryptophan differently depending on your metabolic health. In a healthy state, gut bacteria convert it into protective indoles that support the gut barrier. In states of obesity or high-fat diet consumption, the body's own enzymes (IDO1) take over, producing inflammatory byproducts. Maintaining gut health through diet helps preserve the beneficial bacterial pathway.

Skeletal muscle sarcolipin (SLN)-mediated uncoupling of the SERCA pump increases energy expenditure and prevents diet-induced obesity.

This research suggests that increasing the activity of the Sarcolipin (SLN) protein in your skeletal muscles could help your body burn more calories passively, even at rest. While you cannot currently take a 'SLN pill', this mechanism highlights why maintaining muscle mass (especially slow-twitch fibers) is crucial for metabolic health and weight management. Future therapies may target this pathway to treat obesity without requiring intense physical activity.

Elevated serum levels of the pro-inflammatory cytokine IL-6 and the IL-6/IL-10 ratio are positively associated with the presence of sarcopenia in elderly individuals.

For older adults, high levels of systemic inflammation (specifically IL-6) are linked to muscle loss. While you cannot directly 'dose' IL-6, managing chronic inflammation through diet, exercise, and medical management of inflammatory conditions may help preserve muscle mass. The study highlights that inflammation is a key biological driver, not just a side effect.

Elevated levels of the anti-inflammatory cytokine IL-10 are also positively associated with sarcopenia in the elderly, potentially acting as a compensatory response to chronic inflammation.

High IL-10 levels in sarcopenia may indicate the body's attempt to fight inflammation. This suggests that simply boosting anti-inflammatory markers might not be enough if the underlying pro-inflammatory drive (IL-6) is too strong. Focus on reducing overall inflammatory load.

Administration of the highly proliferative probiotic strain Bifidobacterium animalis ssp. lactis GCL2505 (BlaG) ameliorates metabolic disorders, specifically improving glucose tolerance and reducing visceral fat accumulation, by modulating gut microbiota to elevate acetate levels and subsequently increasing glucagon-like peptide-1 (GLP-1) secretion.

If you are looking to use probiotics to support metabolic health, specifically glucose control and fat management, the specific strain matters significantly. This research suggests that Bifidobacterium animalis ssp. lactis GCL2505, taken daily at 1 billion CFU, may help improve glucose tolerance and reduce visceral fat in the context of a high-fat diet by increasing gut acetate and GLP-1. However, this was observed in mice, and human results may vary. It highlights that 'proliferative' strains might be more effective than non-proliferative ones for these specific outcomes.

Obesity induces systemic DNA damage and inhibits DNA repair mechanisms through chronic inflammation and oxidative stress, thereby increasing the risk of metabolic disorders and cancer.

Maintaining a healthy weight is critical for protecting your DNA from damage caused by inflammation and oxidative stress. This damage accumulates over time and increases the risk of serious conditions like cancer and diabetes. However, the damage is not permanent; losing weight and improving diet quality can reverse this process and restore genomic stability.

IL-22, produced by Th22 cells, has a beneficial effect on NAFLD by alleviating steatosis and reducing transaminase levels through STAT3-mediated mechanisms, although its role in obesity pathogenesis is complex and context-dependent.

IL-22 shows promise in reducing liver fat and inflammation in NAFLD models. While not a current standalone therapy, understanding its protective role highlights the potential of targeting specific cytokine pathways for liver health. Current management focuses on weight loss and metabolic control.